From 2011-14, Thor Sundt, MD served as President of the CTSNet Board of Directors. In this interview, Dr. Sundt reflects on his time as CTSNet president, developments over the past several years, and the organization's future.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Thoracic
May 15, 2014
Betty Tong, Co-Director of the Lung Cancer Screening Program at Duke University Medical Center, discusses the process of establishing a lung cancer screening program.
May 13, 2014
This video shows a left thoracotomy approach to a giant epiphrenic diverticulum in a symptomatic patient.
May 9, 2014
Using the Nationwide Inpatient Sample, the authors evaluated outcomes and costs of VATS (37,595) vs robotic (2,498) lobectomy 2008-2011. Robotic lobectomy was associated with higher rates of complications, particularly cardiovascular and iatrogenic bleeding, and higher costs ($22,582 vs $17,874).
May 7, 2014
At the culmination of years of formal training, cardiothoracic surgery residents are faced with the reality of entering individual practice. Making this transition smoothly, the value of early mentorship, and other pearls are discussed in this roundtable discussion, which was filmed at the 2014 STS Annual Meeting.
May 7, 2014
The University of Pittsburgh experience with anterior approaches to spinal problems is summarized. Approaches included cervical/sternotomy in 8 pts, thoracotomy in 79, and thoracoabominal in 43 for infection (50), primary neoplasms (22), and metastases (58). 30 and 90 day mortality were 9% and 21%, and the major complication rate was 28%. The proc
May 6, 2014
67 patients without a previous history of lung cancer underwent FNA of a GGO with results suspicious for, but not diagnostic of, adenocarcinoma. 47 pts who elected to undergo resection were compared to 16 who opted for observation. 6/16 observed pts developed interval growth or increase in the solid component of the GGO and 5 underwent resection or
May 6, 2014
Clinical outcomes of patients with lung adenocarcinoma were analyzed with respect to the histologic subtype of adenocarcinoma. Histologic pattern was associated with sex, T status, N status, and stage. Recurrence was higher in patients with micropapillary and solid tumors.
May 6, 2014
Outcomes of patients undergoing lung transplant after LVRS were compared to those of patients undergoing LVRS or transplant alone. OR time and LOS were longer in the combined group. Morbidity and mortality were similar among the groups. Post-transplant survival was substantially lower in the combined group. However, if time from LVRS to transplan
May 3, 2014
This systematic review and meta-analysis of individual patient data from 15 RCTs (2385 pts) assessed the utility of preoperative chemotherapy in patients with primarily stages Ib-IIIa NSCLC. Chemotherapy resulted in a 13% reduction in death (HR 0.87, p=0.007), and a 5% survival improvement at 5 years.